LRG1 loss effectively restrains glomerular TGF-β signaling to attenuate diabetic kidney disease is a research paper published in Molecular Therapy (2024). On theSindex it has a DataRank of 0.560. It has been cited 15 times, with 15 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.416
From this paper's citation signal
Citation Network Contribution
0.144
From 9 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 15 citers.
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK129467
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK109683
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK133912
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK122980
National Institute of Diabetes and Digestive and Kidney Diseases
Grant: R01DK131525
U.S. Department of Veterans Affairs
Grant: R01DK117913
U.S. Department of Veterans Affairs
Grant: K01DK125614-01A1
U.S. Department of Veterans Affairs
Grant: I01BX000345
NIDDK NIH HHS
Grant: K01 DK125614
National Institutes of Health
FWCI
2.63
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords